101 related articles for article (PubMed ID: 21404710)
21. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.
McMenamin ME; Soung P; Perera S; Kaplan I; Loda M; Sellers WR
Cancer Res; 1999 Sep; 59(17):4291-6. PubMed ID: 10485474
[TBL] [Abstract][Full Text] [Related]
22. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
[TBL] [Abstract][Full Text] [Related]
23. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
Hellawell GO; Turner GD; Davies DR; Poulsom R; Brewster SF; Macaulay VM
Cancer Res; 2002 May; 62(10):2942-50. PubMed ID: 12019176
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of fragile histidine triad expression in prostate carcinoma.
Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
[TBL] [Abstract][Full Text] [Related]
25. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer].
Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW
Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266
[TBL] [Abstract][Full Text] [Related]
26. Fhit protein expression in human gastric cancer and related precancerous lesions.
Caselli M; Marchisio M; Gaudio M; Saragoni L; Lanza G; Alvisi V; Bertagnolo V; Concu M; Capitani S; Caramelli E
Oncol Rep; 2001; 8(6):1233-7. PubMed ID: 11605039
[TBL] [Abstract][Full Text] [Related]
27. [Expressions of glutathione S-transferase P1 and 4- hydroxynonenal and the progression of prostate cancer].
Song X; Wang R; Xiao F; Zhang SX; Gong M; Wang XL; Zhang Y; Huang JY
Zhonghua Nan Ke Xue; 2017 May; 23(5):412-416. PubMed ID: 29717830
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
[TBL] [Abstract][Full Text] [Related]
29. PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multi-institutional Study of 92 Cases.
Bertsch EC; Magi-Galluzzi C; Cheng L; Osunkoya AO
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):225-230. PubMed ID: 29621096
[TBL] [Abstract][Full Text] [Related]
30. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
Mimori K; Ishii H; Nagahara H; Sudo T; Yamashita K; Inoue H; Barnard GF; Mori M
Cancer Res; 2006 Mar; 66(5):2683-90. PubMed ID: 16510588
[TBL] [Abstract][Full Text] [Related]
31. PTEN Loss in a Prostate Cancer Cohort From Jordan.
Al Bashir S; Alzoubi A; Alfaqih MA; Kheirallah K; Smairat A; Haddad H; Al-Dwairy A; Fawwaz BAB; Alzoubi M; Trpkov K
Appl Immunohistochem Mol Morphol; 2020; 28(5):389-394. PubMed ID: 30614821
[TBL] [Abstract][Full Text] [Related]
32. The expression of FHIT in salivary carcinoma ex pleomorphic adenoma.
Kujan O; Tarakji B; Thakker N; Al Kheraif AA; Sloan P
Anticancer Res; 2012 Aug; 32(8):3147-52. PubMed ID: 22843886
[TBL] [Abstract][Full Text] [Related]
33. [Expression of FHIT and MDM2 in oral submucous fibrosis and canceration tissues].
Yin X; Wen C; Han Y; Gao Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):572-5. PubMed ID: 20622329
[TBL] [Abstract][Full Text] [Related]
34. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
35. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma.
Koksal IT; Dirice E; Yasar D; Sanlioglu AD; Ciftcioglu A; Gulkesen KH; Ozes NO; Baykara M; Luleci G; Sanlioglu S
Urol Oncol; 2004; 22(4):307-12. PubMed ID: 15283888
[TBL] [Abstract][Full Text] [Related]
36. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
37. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
38. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
Shah RB; Bentley J; Jeffery Z; DeMarzo AM
Hum Pathol; 2015 May; 46(5):698-706. PubMed ID: 25724568
[TBL] [Abstract][Full Text] [Related]
40. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Bader G; Iusco D; Salvemini C; Caruso G; Donadei E; Pizzi S; D'Adda T; Renato C; Roncoroni L; Bordi C
Eur J Cancer; 2004 Jul; 40(10):1581-8. PubMed ID: 15196543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]